Mice homozygous for a constitutive Brca2 exon 11 deletion, which abrogates approximately 45% of the Brca2 transcript, succumb to thymic lymphomas (Friedman et al, 1998). This evidence concerns the gene BRCA2 and thymus lymphoma.